Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
13
CVAC Quote, Financials, Valuation and Earnings
Last price:
$4.31
Seasonality move
:
-17.5%
Day range:
$4.24 - $4.35
52-week range:
$2.48 - $5.72
Dividend yield:
0%
P/E ratio:
6.03x
P/S ratio:
11.97x
P/B ratio:
0.95x
Volume:
474.4K
Avg. volume:
1.6M
1-year change:
44.15%
Market cap:
$970.5M
Revenue:
$578.9M
EPS (TTM):
$0.71
Earnings Data
Next earnings date for CVAC
Apr 09
2026
Most recent earnings per share
$1.41
Beat by $1.50
(Nov 12/2025)
Consensus Estimate
-$0.08
(Nov 12/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
CVAC Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 12/31/2025 | Q4 | $15.4M | -- | -- | -$0.11 | -- |
| 11/12/2025 | Q3 | $25.1M | $63.3M | $1.41 | -$0.08 | $1.50 |
| 08/19/2025 | Q2 | $3.9M | $1.4M | -$0.30 | -$0.21 | -$0.09 |
| 05/22/2025 | Q1 | $3.7M | $939.8K | -$0.24 | -$0.21 | -$0.03 |
| 12/31/2024 | Q4 | $21.4M | $15.4M | -$0.16 | -$0.09 | -$0.06 |
| 11/12/2024 | Q3 | $150.6M | $542.6M | $1.65 | $1.54 | $0.11 |
| 08/15/2024 | Q2 | $5.4M | $15.5M | -$0.35 | -$0.28 | -$0.07 |
| 05/23/2024 | Q1 | $13.7M | $13.4M | -$0.34 | -$0.22 | -$0.12 |
| 12/31/2023 | Q4 | $31.5M | $24.3M | -$0.42 | -$0.15 | -$0.27 |
| 11/14/2023 | Q3 | $17M | $17.9M | -$0.24 | -$0.23 | -$0.01 |
| 08/17/2023 | Q2 | -- | $8.2M | -$0.33 | -- | -- |
| 05/30/2023 | Q1 | -- | $7.6M | -$0.29 | -- | -- |
| 12/31/2022 | Q4 | -- | $11.9M | -$0.67 | -- | -- |
| 09/30/2022 | Q3 | -- | $11.3M | -$0.25 | -- | -- |
| 08/18/2022 | Q2 | -- | $21.4M | -$0.33 | -- | -- |
| 05/25/2022 | Q1 | -- | $27.3M | -$0.09 | -- | -- |
| 12/31/2021 | Q4 | -- | $47.1M | -$0.01 | -- | -- |
| 11/19/2021 | Q3 | -- | $34.6M | -$0.91 | -- | -- |
| 08/16/2021 | Q2 | -- | $27M | -$0.98 | -- | -- |
| 05/26/2021 | Q1 | -- | $12.1M | -$0.74 | -- | -- |
| 12/31/2020 | Q4 | -- | $7.2M | -$0.38 | -- | -- |
| 11/30/2020 | Q3 | -- | $6M | -$0.23 | -- | -- |
| 06/30/2020 | Q2 | -- | $38M | -$0.06 | -- | -- |
| 03/31/2020 | Q1 | -- | $3.4M | -$0.14 | -- | -- |
| 12/31/2019 | Q4 | -- | -- | -- | -- | -- |
| 09/30/2019 | Q3 | -- | -- | -- | -- | -- |
| 06/30/2019 | Q2 | -- | -- | -- | -- | -- |
| 03/31/2019 | Q1 | -- | $3.6M | -$0.13 | -- | -- |
| 12/31/2018 | Q4 | -- | -- | -- | -- | -- |
| 09/30/2018 | Q3 | -- | -- | -- | -- | -- |
| 06/30/2018 | Q2 | -- | -- | -- | -- | -- |
| 03/31/2018 | Q1 | -- | -- | -- | -- | -- |
CureVac NV Earnings Questions
-
How Much did CureVac NV Generate in Revenue Last Quarter?
CureVac NV reported $63.3M worth of top line sales in its most recent quarter.
-
Did CureVac NV Beat Earnings Last Quarter?
CureVac NV announced earnings per share of $1.41 which represents a beat of analyst forecast a -$0.08 per share.
-
Is CureVac NV Profitable?
CureVac NV reported $57.9M that represents $0.26 per share over the last quarter.
-
What is the Analyst Consensus for CureVac NV EPS Next Year?
CureVac NV's earnings are forecast to decrease from $0.78 per share to $0.87 per share next year representing a decrease of -82.82%.
-
When is CureVac NV's Earnings Date?
CureVac NV's next earnings date is April 9, 2026.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
